Broken String Biosciences
35 employees on LinkedIn · 5 known investors
Broken String Biosciences develops tools for genome-wide on- and off-target analysis in gene editing, enabling in-house detection and characterization of gene editing-induced DNA breaks. It serves gene editing therapeutic developers working from discovery through IND across diverse cell types and nuclease systems.
Investors · 5
Competitors · 2
by search overlapLabcorp3 shared keywordsLabcorp provides clinical laboratory testing, diagnostics, and lab data services for patients, healthcare providers, and biopharma companies, including genetic health panels, oncology testing, and self-ordered lab tests. It also offers AI-powered tools such as a results-explaining consumer app, a diagnostic assistant integrated into EHRs, and a laboratory data analytics platform to support drug development and clinical research.
Qiita3 shared keywordsQiita is a knowledge-sharing platform where engineers post, share, and edit technical articles, and follow users and tags. It serves software engineers and developers, primarily in Japan, as a community content and knowledge-sharing service.
Companies competing with Broken String Biosciences for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Broken String Biosciences do?
- Broken String Biosciences develops tools for genome-wide on- and off-target analysis in gene editing, enabling in-house detection and characterization of gene editing-induced DNA breaks. It serves gene editing therapeutic developers working from discovery through IND across diverse cell types and nuclease systems.
- Who are Broken String Biosciences's investors?
- Broken String Biosciences's investors include First In Ventures, Heran Partners, Illumina Ventures, Korys, Mérieux Equity Partners.